Related references
Note: Only part of the references are listed.Tumor microenvironment for cancer stem cells
Kazuyoshi Kise et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug Complexes
Janine N. Boodram et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
DNA damage and the balance between survival and death in cancer biology
Wynand P. Roos et al.
NATURE REVIEWS CANCER (2016)
Cobalt(III) Chaperone Complexes of Curcumin: Photoreduction, Cellular Accumulation and Light-Selective Toxicity towards Tumour Cells
Anna K. Renfrew et al.
CHEMISTRY-A EUROPEAN JOURNAL (2015)
Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity
Adriana Albini et al.
CONNECTIVE TISSUE RESEARCH (2015)
Advances in cobalt complexes as anticancer agents
Catherine R. Munteanu et al.
DALTON TRANSACTIONS (2015)
Parthenolide Inhibits Cancer Stem-Like Side Population of Nasopharyngeal Carcinoma Cells via Suppression of the NF-κB/COX-2 Pathway
Kun Liao et al.
THERANOSTICS (2015)
Efficient hydrolytic cleavage of plasmid DNA by chloro-cobalt(II) complexes based on sterically hindered pyridyl tripod tetraamine ligands: synthesis, crystal structure and DNA cleavage
Salah S. Massoud et al.
DALTON TRANSACTIONS (2014)
Synthesis and structure elucidation of a cobalt(II) complex as topoisomerase I inhibitor: In vitro DNA binding, nuclease and RBC hemolysis
Musheer Ahmad et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 ( cyclooxygenase 2) and NOTCH/HES1 and activating PPARG in colorectal cancer
Chang Mo Moon et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Tackling the cancer stem cells - what challenges do they pose?
Diwakar R. Pattabiraman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Metal-mediated DNA damage and cell death: mechanisms, detection methods, and cellular consequences
Carlos Angele-Martinez et al.
METALLOMICS (2014)
Epithelial-to-Mesenchymal Transition Activates PERK-eIF2α and Sensitizes Cells to Endoplasmic Reticulum Stress
Yu-xiong Feng et al.
CANCER DISCOVERY (2014)
Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition
Rebecca Lamb et al.
ONCOTARGET (2014)
Understanding and targeting cancer stem cells: therapeutic implications and challenges
Ke Chen et al.
ACTA PHARMACOLOGICA SINICA (2013)
Cobalt derivatives as promising therapeutic agents
Marie C. Heffern et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2013)
Naproxen intercalates with DNA and causes photocleavage through ROS generation
Mohammed A. Husain et al.
FEBS JOURNAL (2013)
Cross-Bridged Cyclen or Cyclam Co(III) Complexes Containing Cytotoxic Ligands as Hypoxia-Activated Prodrugs
John Yu-Chih Chang et al.
INORGANIC CHEMISTRY (2013)
Hypoxia-inducible Factor-1α (HIF-1α) Promotes Cap-dependent Translation of Selective mRNAs through Up-regulating Initiation Factor eIF4E1 in Breast Cancer Cells under Hypoxia Conditions
Tingfang Yi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Predicting cancer drug mechanisms of action using molecular network signatures
Justin R. Pritchard et al.
MOLECULAR BIOSYSTEMS (2013)
Defining principles of combination drug mechanisms of action
Justin R. Pritchard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Delivery and release of curcumin by a hypoxia-activated cobalt chaperone: a XANES and FLIM study
Anna K. Renfrew et al.
CHEMICAL SCIENCE (2013)
Cobalt complexes with tripodal ligands: implications for the design of drug chaperones
Paul D. Bonnitcha et al.
DALTON TRANSACTIONS (2012)
Dual Targeting of Hypoxic and Acidic Tumor Environments with a Cobalt(III) Chaperone Complex
Natsuho Yamamoto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Proteomic profiling of cancer stem cells derived from primary tumors of HER2/Neu transgenic mice
Deepak Kanojia et al.
PROTEOMICS (2012)
N-alkylated cyclen cobalt(III) complexes of 1-(chloromethyl)-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinolin-5-ol DNA alkylating agent as hypoxia-activated prodrugs
Guo-Liang Lu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Cobalt(II) complexes of terpyridine bases as photochemotherapeutic agents showing cellular uptake and photocytotoxicity in visible light
Sovan Roy et al.
DALTON TRANSACTIONS (2011)
Effect of the central metal ion on the cleavage of DNA by [M(TPA)Cl]ClO4 complexes (M = CoII, CuII and ZnII, TPA = tris(2-pyridylmethyl)amine): An efficient artificial nuclease for DNA cleavage
Wu Xu et al.
INORGANICA CHIMICA ACTA (2011)
Role of COX-2 in Tumorospheres Derived from a Breast Cancer Cell Line
Balraj Singh et al.
JOURNAL OF SURGICAL RESEARCH (2011)
A mammalian functional-genetic approach to characterizing cancer therapeutics
Hai Jiang et al.
NATURE CHEMICAL BIOLOGY (2011)
COX-2 regulates the proliferation of glioma stem like cells
Vivek Sharma et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Visualising the hypoxia selectivity of cobalt(III) prodrugs
Byung J. Kim et al.
CHEMICAL SCIENCE (2011)
Hypoxia inducible factors in cancer stem cells
J. M. Heddleston et al.
BRITISH JOURNAL OF CANCER (2010)
Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells
Kuan-Hsuan Chen et al.
CHILDS NERVOUS SYSTEM (2010)
Syntheses of 8-quinolinolatocobalt(III) complexes containing cyclen based auxiliary ligands as models for hypoxia-activated prodrugs
John Yu-Chih Chang et al.
DALTON TRANSACTIONS (2010)
DNA binding and DNA cleavage studies of a water soluble cobalt(II) complex containing dinitrogen Schiff base ligand: The effect of metal on the mode of binding
Nahid Shahabadi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Molecular Basis for Cyclooxygenase Inhibition by the Non-steroidal Anti-inflammatory Drug Naproxen
Kelsey C. Duggan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
Zhizhong Li et al.
CANCER CELL (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype
John M. Heddleston et al.
CELL CYCLE (2009)
Synthesis and Evaluation of Stable Bidentate Transition Metal Complexes of 1-(Chloromethyl)-5-hydroxy-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinoline (seco-6-azaCBI-TMI) as Hypoxia Selective Cytotoxins
Jared B. J. Milbank et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
A MT1-MMP/NF-κB signaling axis as a checkpoint controller of COX-2 expression in CD133(+) U87 glioblastoma cells
Borhane Annabi et al.
JOURNAL OF NEUROINFLAMMATION (2009)
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
A. Soeda et al.
ONCOGENE (2009)
Stem cell niche: Microenvironment and beyond
Jiwang Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Cellular uptake and distribution of cobalt complexes of fluorescent ligands
Natsuho Yamamoto et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2008)
Bioreductive activation and drug chaperoning in cobalt pharmaceuticals
Matthew D. Hall et al.
DALTON TRANSACTIONS (2007)
Studies of a cobalt(III) complex of the MMP inhibitor marimastat: A potential hypoxia-activated prodrug
Timothy W. Failes et al.
CHEMISTRY-A EUROPEAN JOURNAL (2007)
COX-2 expression in invasive breast cancer - Correlation with prognostic parameters and outcome
Aziza Nassar et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2007)
Radiolytic and cellular reduction of a novel hypoxia-activated cobalt(III) prodrug of a chloromethylbenzindoline DNA minor groove alkylator
G-One Ahn et al.
BIOCHEMICAL PHARMACOLOGY (2006)
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
G Dontu et al.
GENES & DEVELOPMENT (2003)
ATM phosphorylates histone H2AX in response to DNA double-strand breaks
S Burma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1
R Melchionna et al.
NATURE CELL BIOLOGY (2000)
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
S Matsuoka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
